Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$14.44 - $18.83 $197,828 - $257,970
13,700 Added 67.49%
34,000 $507,000
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $182,770 - $225,694
9,800 Added 93.33%
20,300 $388,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $511,285 - $643,428
-29,300 Reduced 73.62%
10,500 $217,000
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $1,378 - $1,880
100 Added 0.25%
39,800 $748,000
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $351,495 - $555,972
32,100 Added 422.37%
39,700 $572,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $338,436 - $484,908
-20,400 Reduced 72.86%
7,600 $131,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $2.33 Million - $2.98 Million
-120,900 Reduced 81.2%
28,000 $582,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $2.39 Million - $3.58 Million
-111,500 Reduced 42.82%
148,900 $3.5 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $4.28 Million - $5.25 Million
183,500 Added 238.62%
260,400 $7.28 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $1.61 Million - $2.36 Million
68,800 Added 849.38%
76,900 $1.8 Million
Q2 2022

Aug 08, 2022

BUY
$31.66 - $38.9 $12,664 - $15,560
400 Added 5.19%
8,100 $273,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $234,465 - $303,072
7,700 New
7,700 $269,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $157,685 - $204,215
-5,500 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $20,899 - $26,017
-730 Reduced 11.72%
5,500 $180,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $177,243 - $236,740
6,230 New
6,230 $189,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.94B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.